SPG(SH:600529)2024-01-25 10:32Group 1: Sales and Growth - In 2023, the sales of borosilicate pharmaceutical glass products maintained a rapid growth rate, with contributions to revenue and profit continuing to expand [2][3] - The company expects to continue expanding the production capacity of borosilicate pharmaceutical glass based on market demand in 2024 [3] - The company experienced significant growth in foreign trade, with foreign trade revenue accounting for approximately one-third of total revenue, driven mainly by the increase in sales of brown bottles and ordinary soda-lime molded bottles [4] Group 2: Cost and Material Prices - In 2023, the prices of key raw materials such as soda ash and borax remained at historical highs, while soda ash prices decreased compared to 2022 [3] - Energy prices for coal and natural gas saw a slight decline compared to 2022, but remained high compared to 2021 [3] Group 3: Production and Quality - The company currently operates one electric melting furnace for borosilicate glass tubes, achieving a yield rate of approximately 60%, with mass production specifications reaching around 70% [4] - The self-use rate of borosilicate glass tubes is over 50% [4] Group 4: Research and Development - The company has been increasing its investment in product research and development in recent years to enhance its core competitiveness [4] Group 5: Communication and Transparency - The company ensured that the communication with investors was thorough and adhered to its information disclosure management regulations, maintaining the accuracy and completeness of disclosed information [5]